Most sold healthcare stocks in Q3 2025
See which Healthcare stocks institutional investors trimmed or exited the most in Q3 2025, measured as net reductions in reported share positions from Q2 2025 into Q3 2025. Notable reductions at the top of this list include BAUSCH HEALTH COS INC (BHC), TEVA PHARMACEUTICAL-SP ADR (TEVA), HALEON PLC-ADR (HLN), EVOLENT HEALTH INC - A (EVH). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | -34,193,429 | -$228.27M | 1 | 2 | 0 | 1 | 4 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -11,502,212 | -$160.31M | 0 | 1 | 4 | 0 | 5 |
| HLN | HALEON PLC-ADR | -7,219,647 | -$297.63M | 0 | 1 | 5 | 0 | 6 |
| EVH | EVOLENT HEALTH INC - A | -6,303,750 | -$87.71M | 1 | 0 | 1 | 1 | 2 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -5,374,060 | -$5.43M | 0 | 0 | 1 | 0 | 1 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | -4,887,200 | -$8.41M | 0 | 0 | 0 | 1 | 0 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -4,294,487 | -$256.24M | 1 | 1 | 2 | 0 | 4 |
| UNH | UNITEDHEALTH GROUP INC | -3,689,741 | -$323.17M | 3 | 10 | 7 | 5 | 23 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -3,162,253 | -$281.00M | 0 | 2 | 2 | 2 | 5 |
| SNY | SANOFI-ADR | -3,006,563 | -$222.89M | 0 | 2 | 2 | 2 | 4 |
| ABT | ABBOTT LABORATORIES | -2,869,313 | -$414.00M | 1 | 2 | 3 | 0 | 10 |
| MRSN | MERSANA THERAPEUTICS INC | -2,850,194 | -$843.66K | 0 | 0 | 0 | 1 | 0 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | -2,780,900 | -$5.68M | 0 | 0 | 1 | 0 | 1 |
| TMO | THERMO FISHER SCIENTIFIC INC | -2,678,426 | -$760.47M | 1 | 2 | 5 | 2 | 10 |
| GERN | GERON CORP | -2,634,820 | -$3.81M | 0 | 0 | 1 | 0 | 1 |
| GBIO | GENERATION BIO CO | -2,580,780 | -$826.11K | 0 | 0 | 0 | 1 | 0 |
| BBIO | BRIDGEBIO PHARMA INC | -2,500,711 | $35.12M | 0 | 2 | 1 | 0 | 3 |
| TXG | 10X GENOMICS INC-CLASS A | -2,432,041 | -$26.74M | 0 | 0 | 2 | 0 | 2 |
| OSCR | OSCAR HEALTH INC - CLASS A | -2,373,021 | -$50.93M | 0 | 0 | 1 | 2 | 1 |
| GH | GUARDANT HEALTH INC | -2,164,528 | -$98.61M | 0 | 1 | 2 | 0 | 3 |
| PFMT | PERFORMANT FINANCIAL CORP | -2,126,755 | -$3.96M | 0 | 0 | 2 | 0 | 2 |
| LLY | ELI LILLY & CO | -2,008,351 | -$1.62B | 0 | 3 | 5 | 3 | 10 |
| CVS | CVS HEALTH CORP | -1,640,868 | $483.81M | 0 | 1 | 10 | 1 | 12 |
| DVA | DAVITA INC | -1,635,936 | -$541.16M | 0 | 1 | 1 | 0 | 2 |
| PASG | PASSAGE BIO INC | -1,416,399 | -$566.98K | 0 | 0 | 0 | 1 | 0 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -1,381,702 | -$15.86M | 0 | 0 | 0 | 2 | 0 |
| ZTS | ZOETIS INC | -1,292,040 | -$215.12M | 0 | 4 | 5 | 0 | 12 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -1,181,990 | -$65.24M | 0 | 3 | 0 | 1 | 4 |
| MYGN | MYRIAD GENETICS INC | -1,180,656 | -$6.23M | 0 | 0 | 1 | 1 | 1 |
| JNJ | JOHNSON & JOHNSON | -1,128,008 | -$57.06M | 0 | 2 | 9 | 0 | 15 |
| NTLA | INTELLIA THERAPEUTICS INC | -1,124,598 | $88.63M | 0 | 0 | 2 | 0 | 2 |
| SAGE | SAGE THERAPEUTICS INC | -1,113,400 | -$10.15M | 0 | 0 | 0 | 1 | 0 |
| SENS | SENSEONICS HOLDINGS INC | -1,053,183 | -$570.83K | 0 | 0 | 1 | 0 | 1 |
| VERV | VERVE THERAPEUTICS INC | -1,047,600 | -$11.76M | 0 | 0 | 0 | 1 | 0 |
| BMY | BRISTOL-MYERS SQUIBB CO | -1,040,021 | -$79.88M | 0 | 5 | 4 | 1 | 10 |
| GILD | GILEAD SCIENCES INC | -1,038,579 | -$110.46M | 0 | 1 | 5 | 0 | 6 |
| ABBV | ABBVIE INC | -1,025,459 | -$132.64M | 1 | 4 | 3 | 0 | 12 |
| MRNA | MODERNA INC | -1,003,900 | -$27.70M | 0 | 0 | 0 | 1 | 0 |
| GSK | GSK PLC-SPON ADR | -954,457 | $354.12M | 0 | 3 | 5 | 0 | 8 |
| ICAD | ICAD INC | -928,632 | -$3.54M | 0 | 0 | 0 | 2 | 0 |
| BFLY | BUTTERFLY NETWORK INC | -911,449 | -$2.25M | 0 | 0 | 1 | 2 | 1 |
| OPCH | OPTION CARE HEALTH INC | -894,108 | -$69.62M | 0 | 0 | 2 | 0 | 2 |
| MREO | MEREO BIOPHARMA GROUP PL-ADR | -889,600 | -$2.79M | 0 | 0 | 1 | 0 | 1 |
| WRBY | WARBY PARKER INC-CLASS A | -888,478 | $41.50M | 0 | 1 | 3 | 0 | 4 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | -875,182 | $21.62M | 1 | 1 | 2 | 0 | 4 |
| MOH | MOLINA HEALTHCARE INC | -810,011 | -$288.97M | 1 | 1 | 1 | 2 | 3 |
| HCA | HCA HEALTHCARE INC | -780,162 | -$65.70M | 1 | 2 | 2 | 0 | 6 |
| LFST | LIFESTANCE HEALTH GROUP INC | -765,400 | -$3.36M | 0 | 1 | 1 | 0 | 2 |
| SWTX | SPRINGWORKS THERAPEUTICS INC | -760,600 | -$35.74M | 0 | 0 | 0 | 1 | 0 |
| TVTX | TRAVERE THERAPEUTICS INC | -743,000 | $4.95M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q3 2025
What are the most sold Healthcare stocks in Q3 2025?
The most sold healthcare stocks in Q3 2025 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q2 2025, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q3 2025?
Among the managers we track, net reductions were largest in companies such as BAUSCH HEALTH COS INC (BHC), TEVA PHARMACEUTICAL-SP ADR (TEVA), HALEON PLC-ADR (HLN), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q2 2025).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.